Santa Farma İlaç Leads Turkey in Pharmaceutical Sector Patents

Santa Farma Pharmaceutical: Turkey's Patent Leader in the Pharmaceutical Sector Santa Farma Pharmaceutical continues to register its innovations in technology and research. In the "2021 European Patent Application (EP) Registration Leadership Table by Number," compiled by Patent Effect, a firm that provides innovation strategy support to institutions through patent data analysis using 2021 data from the first 11 months, Santa Farma Pharmaceutical ranked 12th with 3 registered European Patents (EP).

Only Santa Farma Pharmaceutical on the List

Santa Farma Pharmaceutical became the only pharmaceutical company that could make it onto the list with its know-how capacity, innovative product development systematization and approach. Among Turkey's most established pharmaceutical companies, Santa Farma Pharmaceutical operates in 10 distinct therapeutic categories and a total of 73 products across 50 separate markets within these categories, together with a patent portfolio consisting of more than 60 patents and patent applications developed annually and as of 2022. The therapeutic categories in question are listed as Dermatology, Digestive System and Metabolism, Gastroenterology and Infection, Hematology, Cardiovascular System, Musculoskeletal System, Radiology, Nervous System (CNS), Respiratory System, and Urogenital System. The company's production facility in GEBKİM OSB operates with 44,000 m2 of enclosed space and an annual production capacity of 150 million boxes.